Dale Schenk, a leader in the field of Alzheimer’s disease immunotherapy passed away Friday, September 30, after a battle with pancreatic cancer that started in 2014. Schenk had been working until ...

Dale Schenk, the co-founder and chief executive officer at Prothena Corp. who devoted his scientific career to researching neurological diseases such as Alzheimer’s and Parkinson’s ...

Getting a cancer diagnosis will put life in perspective. In late 2014, Dale Schenk got the news that he had pancreatic cancer. Following the cancer diagnosis, Schenk quickly underwent surgery ...

Turning to the agenda, speaking on today's call, we have Dr. Dale Schenk, our President and Chief Executive Officer, who will discuss our 2015 highlights and corporate accomplishments; Dr. Gene ...

But Elan chief scientific officer Dale Schenk staunchly defends the company's approach to treating Alzheimer's Disease. In a long interview, he calmly brushed off critics who say that the drug ...

Immunotherapy researcher Dale Schenk, who made pioneering strides toward developing an Alzheimer’s disease vaccine, died last month (September 30). The cause was pancreatic cancer, Bloomberg reported.

"Of course, mice aren't humans," cautions Dale Schenk, Elan's lead scientist. Researchers have determined Alzheimer's is caused by the build-up of protein-based plaques in the brain which disrupt ...

You might flag down Dale from IT, if he walks by your office when Schenk comes on the screen, and ask him a question. “Hey, Dale!” you’ll say. “Guess what this pro golfer’s parents did ...

Prothena Corporation plc (NASDAQ:PRTA) Q4 2014 Results Earnings Conference Call March 5, 2015 4:30 PM ETExecutivesDale Schenk - Chief Executive OfficerTran ...